Colgate-Palmolive (CL) Shares Sold by Millennium Management LLC

Millennium Management LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 16.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 597,647 shares of the company’s stock after selling 119,582 shares during the quarter. Millennium Management LLC owned about 0.07% of Colgate-Palmolive worth $35,572,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Kaizen Advisory LLC increased its position in Colgate-Palmolive by 21.8% during the 4th quarter. Kaizen Advisory LLC now owns 2,411 shares of the company’s stock worth $144,000 after purchasing an additional 432 shares in the last quarter. Lowe Brockenbrough & Co. Inc. increased its position in Colgate-Palmolive by 1.2% during the 4th quarter. Lowe Brockenbrough & Co. Inc. now owns 40,849 shares of the company’s stock worth $2,431,000 after purchasing an additional 480 shares in the last quarter. grace capital increased its position in Colgate-Palmolive by 177.8% during the 4th quarter. grace capital now owns 2,500 shares of the company’s stock worth $149,000 after purchasing an additional 1,600 shares in the last quarter. River & Mercantile Asset Management LLP acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $7,765,000. Finally, National Pension Service increased its position in Colgate-Palmolive by 5.7% during the 4th quarter. National Pension Service now owns 818,132 shares of the company’s stock worth $53,547,000 after purchasing an additional 44,167 shares in the last quarter. 76.27% of the stock is owned by institutional investors.

In related news, Director John T. Cahill sold 5,780 shares of the firm’s stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the transaction, the director now directly owns 27,820 shares in the company, valued at $1,793,277.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ian M. Cook sold 17,750 shares of the firm’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $68.61, for a total value of $1,217,827.50. Following the transaction, the insider now owns 1,111,293 shares in the company, valued at $76,245,812.73. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 103,200 shares of company stock valued at $6,900,449. Company insiders own 1.14% of the company’s stock.

A number of analysts recently issued reports on CL shares. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Wednesday, January 2nd. Goldman Sachs Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Evercore ISI initiated coverage on shares of Colgate-Palmolive in a research report on Thursday, January 10th. They set an “outperform” rating and a $70.00 target price for the company. Wells Fargo & Co reaffirmed a “hold” rating and issued a $57.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 25th. Finally, Morgan Stanley set a $62.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Tuesday, January 29th. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $65.73.

NYSE:CL traded up $0.67 during trading hours on Friday, hitting $69.35. The stock had a trading volume of 3,369,043 shares, compared to its average volume of 2,923,168. The company has a quick ratio of 0.76, a current ratio of 1.14 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $70.98. The company has a market capitalization of $59.63 billion, a price-to-earnings ratio of 23.35, a price-to-earnings-growth ratio of 4.55 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 25th. The company reported $0.74 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.73 by $0.01. The company had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business’s revenue was down 2.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.75 EPS. On average, equities analysts anticipate that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.43 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 annualized dividend and a dividend yield of 2.48%. The ex-dividend date of this dividend is Wednesday, April 17th. Colgate-Palmolive’s dividend payout ratio is 57.91%.

ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive (CL) Shares Sold by Millennium Management LLC” was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/04/22/millennium-management-llc-sells-119582-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: What Does a Sell-Side Analyst Rating Mean?

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.